Evidence map›Paper›PMID 39947807›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2025

OPTN/SRTR 2023 Annual Data Report: Heart.

Monica M Colvin, Jodi M Smith, Yoon Son Ahn, Kelsi A Lindblad, Dzhuliyana Handarova, Ajay K Israni, Jon J Snyder

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. The future of heart transplant data science requires common data models.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2026
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Monica M ColvinScientific Registry of Transplant Recipients, Hennepin Healthcare Research Institute, Minneapolis, MN; Department of Cardiology, University of Michigan, Ann Arbor, MI.
Jodi M SmithScientific Registry of Transplant Recipients, Hennepin Healthcare Research Institute, Minneapolis, MN; Department of Pediatrics, University of Washington, Seattle, WA.
Yoon Son AhnScientific Registry of Transplant Recipients, Hennepin Healthcare Research Institute, Minneapolis, MN.
Kelsi A LindbladOrgan Procurement and Transplantation Network, United Network for Organ Sharing, Richmond, VA.
Dzhuliyana HandarovaOrgan Procurement and Transplantation Network, United Network for Organ Sharing, Richmond, VA.
Ajay K IsraniScientific Registry of Transplant Recipients, Hennepin Healthcare Research Institute, Minneapolis, MN; Department of Medicine, University of Texas Medical Branch, Galveston, TX.
Jon J SnyderScientific Registry of Transplant Recipients, Hennepin Healthcare Research Institute, Minneapolis, MN; Department of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN; Department of Medicine, Hennepin Healthcare, University of Minnesota, Minneapolis, MN.

Funding

AHRQ HHS R01 HS028829
6 · The paper itself

Abstract

Despite unintended consequences and ongoing need for revision, the 2018 adult heart transplant policy revision continues to have a favorable impact as evidenced by increased transplant rates, decreased waitlist mortality, and more rapid transplant in higher acuity patients. In 2023, the total number of heart transplants in the United States increased 101.1% since 2012, reaching a record 4,599, of which 4,092 were performed in adults. Between 2022 and 2023 alone, 424 more adult heart transplants were performed, the largest annual increase this decade. Concurrently, the prevalence of heart donors after circulatory death increased to 14.0% in 2023. Candidates listed at adult statuses 1 and 2 underwent transplant more quickly (2,225.8 and 1,088.1 transplants per 100 patient-years, respectively). In 2023, adult waitlist mortality reached a low: 8.5 deaths per 100 patient-years. Multiorgan transplants (heart-liver and heart-kidney) in adults continue to increase, achieving comparable survival to that of heart transplant alone. Adults with congenital heart disease had the lowest pretransplant mortality of all diagnoses but also the lowest posttransplant survival, 76.1% at 5 years, emphasizing the need for consensus on best practices. In pediatric heart transplant, heart transplants increased 36.3% and new listings increased 34.0%, but the transplant rate decreased 14.9% resulting in increased waiting times. High-urgency listings increased, with 83.6% of heart transplants performed for status 1A. Pediatric waitlist mortality has declined 53.4% since 2012, but remains substantial: 11.7 deaths per 100 patient-years. In 2023, 5-year posttransplant survival was 80.3% in adult recipients and 84.4% in pediatric recipients.

Indexed as

Annual Reports as TopicHeart TransplantationRegistriesTissue and Organ ProcurementTissue DonorsWaiting ListsAdultFemaleHumansMalePrognosisSurvival RateUnited StatesAllocationdonorheart failureheart transplantleft ventricular assist devicemechanical circulatory supportoutcomes

Identifiers

PMID39947807
PMCPMC12414510

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.